Literature DB >> 25535184

Combined microwave thermal ablation and liver resection for single step treatment of otherwise unresectable colorectal liver metastases; a monoistitutional experiences.

A Tropea1, A Biondi, A Corsaro, M Donati, F Basile, S Gruttadauria.   

Abstract

OBJECTIVE: Over half of colorectal cancer patients will develop liver metastases.
BACKGROUND: Thermal ablation with or without associated liver resection for colorectal hepatic metastasis has been suggested as an alternative method to improve survival if radical surgical resection is not achievable. A retrospective case series of patients treated with microwave ablation(MWA) associated with hepatic resection in one step procedure, was reviewed to analyze the clinical outcome.
MATERIALS AND METHODS: In a group of 40 patients surgically cured for liver tumors in our Department, 5 patients with technically unresectable disease underwent combined treatment LR-MWA.
RESULTS: Four patients were treated with multiple segmentectomies and MWA and one patient received a left lobectomy (S2-S3) and MWA. Only 1 patient (20%) developed post surgical complication which was a liver abscess (grade II of Dindo classification).
CONCLUSIONS: Hepatic resection combined with MWA expanded indications for operative treatment of multiple bilobar liver metastasis. This procedure promise to have good long-term outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 25535184

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  A new system of microwave ablation at 2450 MHz: preliminary experience.

Authors:  Anna Maria Ierardi; Alberto Mangano; Chiara Floridi; Gianlorenzo Dionigi; Antonio Biondi; Ejona Duka; Natalie Lucchina; Georgios D Lianos; Gianpaolo Carrafiello
Journal:  Updates Surg       Date:  2015-03-17

2.  Effect of combination therapy of siRNA targeting growth hormone receptor and 5-fluorouracil in hepatic metastasis of colon cancer.

Authors:  Dong Zhou; Y I Zhang; Daoming Liang; Yong Yuan; Demiao Zeng; Jiayong Chen; Jie Yang
Journal:  Oncol Lett       Date:  2015-09-30       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.